Skip to main content
. 2010 Mar 5;78(2):215–231. doi: 10.3797/scipharm.0912-14

Tab. 3.

Results of recovery study:

Name of the impurity Amount spikeda % Recoveryb
50% 100% 150% 50% 100% 150%
10-Deacetylbaccatin III 0.15 0.3 0.45 99.1 100.2 99.3
2′,3′-Epidocetaxel 0.15 0.3 0.45 100.1 100.5 99.4
2′-Epidocetaxel 0.15 0.3 0.45 98.2 99.5 98.2
Oxetane ring opened impurity of Docetaxel 0.15 0.3 0.45 97.8 98.2 97.5
10-Oxodocetaxel 0.15 0.3 0.45 99.6 99.7 96.7
7′-Epidocetaxel 0.15 0.3 0.45 96.4 95.7 97.5
10-Oxo-7′-epidocetaxel 0.15 0.3 0.45 98.9 97.2 96.5
a

Amount of impurities spiked with respect to 0.30% specification level individually to 0.8 mg/ml of docetaxel;

b

Mean±%RSD for three determinations.